Literature DB >> 8942746

Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats.

Y Yoshida1, Y Tokusashi, G H Lee, K Ogawa.   

Abstract

BACKGROUND & AIMS: Long-Evans cinnamon (LEC) rats are an animal model of Wilson's disease. This study investigated whether intrahepatic transplantation of normal hepatocytes can prevent Wilson's disease in LEC rats.
METHODS: Hepatocytes of newborn Long-Evans agouti (LEA) rats were transplanted into the livers of LEC rats before onset of hepatic disease. Expression of normal transcripts from the gene linked to Wilson's disease was investigated at 30 weeks of age by reverse-transcription polymerase chain reaction and in situ hybridization.
RESULTS: Eight of 16 (50.0%) untreated LEC rats died of hepatic failure during 20-30 weeks of age. Of the 27 LEC rats with transplanted cells, 2 (7.4%) died of hepatic failure and 4 died of ileus complicated by the surgical treatment. In the recipient livers, the transplanted cells comprised 4%-20% of the hepatocyte populations, expressing normal messenger RNA transcribed from the Wilson's disease gene, and hepatic copper deposition was reduced to approximately 60% of that in untreated LEC rats.
CONCLUSIONS: Transplantation of normal hepatocytes prevents Wilson's disease in LEC rats.

Entities:  

Mesh:

Year:  1996        PMID: 8942746     DOI: 10.1016/s0016-5085(96)70029-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

Review 1.  Hepatocyte transplantation for inborn errors of metabolism.

Authors:  A B Burlina
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 2.  Principles of therapeutic liver repopulation.

Authors:  Markus Grompe
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 3.  Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.

Authors:  Ira J Fox; George Q Daley; Steven A Goldman; Johnny Huard; Timothy J Kamp; Massimo Trucco
Journal:  Science       Date:  2014-08-22       Impact factor: 47.728

Review 4.  Human hepatocyte transplantation: current experience and future challenges.

Authors:  Anil Dhawan; Juliana Puppi; Robin D Hughes; Ragai R Mitry
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

Review 5.  Liver repopulation for the treatment of metabolic diseases.

Authors:  M Grompe
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

Review 6.  Animal models of Wilson disease.

Authors:  Emily Reed; Svetlana Lutsenko; Oliver Bandmann
Journal:  J Neurochem       Date:  2018-06-26       Impact factor: 5.372

Review 7.  Cell-based liver therapies: past, present and future.

Authors:  Valeria Iansante; Anil Chandrashekran; Anil Dhawan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 8.  Menkes copper-translocating P-type ATPase (ATP7A): biochemical and cell biology properties, and role in Menkes disease.

Authors:  Ilia Voskoboinik; James Camakaris
Journal:  J Bioenerg Biomembr       Date:  2002-10       Impact factor: 2.945

9.  Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease.

Authors:  Raymond D Hickey; Shennen A Mao; Jaime Glorioso; Joseph B Lillegard; James E Fisher; Bruce Amiot; Piero Rinaldo; Cary O Harding; Ronald Marler; Milton J Finegold; Markus Grompe; Scott L Nyberg
Journal:  Stem Cell Res       Date:  2014-05-14       Impact factor: 2.020

Review 10.  Stem cells in liver regeneration and therapy.

Authors:  Tobias Cantz; Michael P Manns; Michael Ott
Journal:  Cell Tissue Res       Date:  2007-09-28       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.